Here is the latest shareholding Pattern of GLENMARK LIFE SCIENCES. For more details, see the GLENMARK LIFE SCIENCES financial fact sheet and GLENMARK LIFE SCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | 82.85 | |
Mutual Funds | % | 0.71 | 0.71 | 0.00 | 0.00 | 0.52 | 0.38 | 0.59 | 0.93 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.07 | 0.07 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 7.58 | 6.03 | 4.45 | 3.28 | 3.27 | 4.39 | 4.57 | 5.01 | |
Other | % | 0.08 | 0.02 | 0.03 | 0.01 | 0.06 | 0.10 | 0.15 | 0.47 | |
Total Institution | % | 8.37 | 6.83 | 4.55 | 3.29 | 3.85 | 5.02 | 5.31 | 6.41 | |
Bodies Corporate | % | 0.32 | 0.36 | 1.96 | 2.02 | 2.09 | 2.04 | 1.95 | 0.88 | |
Individuals | % | 8.14 | 9.14 | 9.78 | 10.87 | 10.02 | 9.21 | 9.20 | 9.09 | |
NRIs/OCBs | % | 0.32 | 0.46 | 0.52 | 0.64 | 0.84 | 0.56 | 0.42 | 0.53 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | -0.00 | 0.35 | 0.34 | 0.33 | 0.35 | 0.31 | 0.27 | 0.23 | |
Total Non-Institution | % | 8.78 | 10.31 | 12.60 | 13.86 | 13.30 | 12.12 | 11.84 | 10.73 | |
Total Public | % | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.47 | 9.47 | 9.47 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Indian share markets continued the momentum as the session progressed and ended the higher.